- OPKO enters definitive agreement to sell substantially all remaining BioReference operations to Labcorp for $722M in cash.
- Q3 reported continuing operations net loss of $(0.05) per share vs $(0.04) in prior-year period.
- Significant cash injection fundamentally reshapes balance sheet despite ongoing operating losses.
Signal #135602 · SEC 8-K
$OPK SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $OPK filing catalyst
Why did $OPK trigger an AI stock catalyst alert?
$OPK triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: OPKO Health to Sell BioReference Assets to Labcorp for $722 Million in Cash. Key points: - OPKO enters definitive agreement to sell substantially all remaining BioReference operations to Labcorp for $722M in cash. - Q3 reported continuing operations net loss of $(0.05) per share vs $(0.04) in prior-year period. - Significant cash injection fundamentally reshapes balance sheet despite ongoing operating losses.
How did $OPK stock react after the SEC filing?
After the SEC 8-K for $OPK, observed market reaction: T0 price $1.77. Past moves do not guarantee future results.
Where can I get real-time $OPK SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $OPK via Telegram and the VIP Web Terminal from €10/month.